Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT00148707CompletedBreast Cancer | Metastatic Breast Cancer
-
NCT00319618CompletedMetastatic Breast Cancer
-
NCT01939483WithdrawnMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | Central Nervous System Metastases
-
NCT07434817Not yet recruitingNewly Diagnosed Breast Cancer | Breast Cancer Females
-
NCT07544056Not yet recruitingMetastatic Triple-negative Breast Cancer | Locally Advanced Triple-negative Breast Cancer
-
NCT05559528RecruitingMetastatic Breast Cancer | Breast Cancer Stage IV
-
NCT05362760RecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast Cancer
-
NCT04622319Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast Cancer
-
NCT07536815AvailableTNBC, Triple Negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | TNBC
-
NCT03709446CompletedBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast Cancer
-
NCT02778685Active, not recruitingStage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast Carcinoma
-
-
NCT04095689TerminatedTriple Negative Breast Cancer | Anthracycline-refractory TNBC
-
NCT01722851CompletedBreast Cancer | Recurrent Breast Cancer | Newly Diagnosed Breast Cancer
-
NCT01492101CompletedMetastatic Breast Cancer | Locally Recurrent Breast Cancer
-
NCT01730729CompletedStage IV Breast Cancer | Recurrent Breast Cancer
-
NCT01912963TerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer
-
NCT01520103CompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast Cancer
-
NCT00054132CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma
-
NCT00053339WithdrawnStage IV Breast Cancer | Recurrent Breast Cancer
-
NCT00065325CompletedMetastatic Breast Cancer | Locally Advanced Breast Cancer
-
NCT00217399CompletedStage IV Breast Cancer | Recurrent Breast Cancer
-
-
NCT00003455WithdrawnStage IV Breast Cancer | Recurrent Breast Cancer
-
NCT00055861CompletedStage IV Breast Cancer | Recurrent Breast Cancer
-
NCT00477100RecruitingInvasive Breast Carcinoma | Inflammatory Breast Carcinoma | Second Primary Malignant Neoplasm
-
NCT05054374CompletedBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IV | Solid Carcinoma | HER2-negative Breast Cancer | MEK1 Gene Mutation | MEK2 Gene Mutation
-
NCT06931548RecruitingBreast Cancer Stage I | Breast Cancer Stage II | In Situ Breast Cancer
-
NCT04603209RecruitingBreast Neoplasms | Early-stage Breast Cancer | Breast Carcinoma in Situ
-
NCT04584255Active, not recruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | HER2-negative Breast Cancer | Stage III Breast Cancer | Deleterious PALB2 Gene Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene Mutation
-
NCT02668666CompletedMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive Tumor
-
NCT03599453CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple -Negative Breast Cancer | Anatomic Stage IV Breast Cancer AJCC
-
NCT07590583Not yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Hormone Receptor-Positive Breast Carcinoma | Unresectable Hormone Receptor-Positive Breast Carcinoma | Advanced Hormone Receptor-Positive Breast Carcinoma
-
-
NCT06676761RecruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)
-
NCT06026657RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma
-
NCT05608252RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer
-
NCT05550415RecruitingTriple Negative Breast Cancer | Chemotherapy Effect | Simvastatin Adverse Reaction
-
NCT05288127RecruitingTriple Negative Breast Cancer | HRD 100 Gene Expression High
-
NCT03067935No longer availableMetastatic gpNMB Expressing Triple Negative Breast Cancer
-
NCT00371254CompletedBreast Cancer | Metastasis
-
NCT07227831Not yet recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor
-
NCT06502691RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma
-
NCT06075810RecruitingBreast Cancer | Breast Neoplasm | Breast Cancer Stage IV
-
NCT05828238RecruitingPositron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor EfficacySolid Tumor | Breast Cancer Stage II | Breast Cancer Stage III
-
NCT05730608RecruitingBreast Cancer Recurrent | Breast Cancer Female
-
NCT05309655RecruitingBreast Cancer | Triple Negative Breast Cancer | Cardiovascular Complications
-
NCT04947189Recruiting
-
NCT03577197RecruitingAdvanced Breast Cancer | Metastatic Breast Cancer
-
NCT02390427CompletedMetastatic Breast Cancer | Recurrent Breast Cancer
-
NCT06500858CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma
-
NCT03356860CompletedBreast Cancer | Triple Negative Breast Cancer | Luminal B
-
NCT06671691Enrolling by invitationSBRT | Breast Cancer Early Stage Breast Cancer (Stage 1-3)